CAS: 114-70-5; Sodium,2-Phenylacetate

上下游产品

CAS号103-82-2 苯乙酸 | CAS号67-56-1 甲醇 | CAS号201230-82-2 carbon monoxide | CAS号100-44-7 氯化苄 | CAS号124-38-9 二氧化碳 | CAS号1121-53-5 苄基钠 | CAS号101-97-3 苯乙酸乙酯 | CAS号4870-65-9 alpha-溴苯乙酸 | CAS号7584-72-7 2,3-diphenylsuc... | CAS号103-82-2 苯乙酸 | CAS号4861-85-2 苯乙酸异丙酯 | CAS号91-48-5 α-苯基肉桂酸 | CAS号91-47-4 苯可丁酸 | CAS号103-30-0 反式-1,2二苯乙烯 | CAS号588-59-0 二苯乙烯 | CAS号22535-03-1 2-phenylacetyl ... | CAS号201737-94-2 [2-(4-methylsul...

专利信息

专利号:US-4334079-A
优先权日:1980-11-03
标 题:Synthesis of substituted benzyl esters
发明人：GREENE JAMES M; BUNNELL CHARLES A
权利人:LILLY CO ELI
摘要:A process for preparing certain substituted benzyl esters of phenylacetic acids by esterification in a solvent in which the salt of the acid is insoluble, and in the presence of a phase transfer catalyst.

专利号:WO-9709067-A1
优先权日:1995-09-05
标 题 :Combination of 5-lipoxygenase and leukotriene synthesis inhibitors with glucocorticosteroids
发明人：BURCHARDT ELMAR-REINHOLD; MUELLER-PEDDINGHAUS REINER
权利人:BAYER AG; BURCHARDT ELMAR REINHOLD; MUELLER PEDDINGHAUS REINER
摘要:The combination is disclosed of 5-lipoxygenase inhibitors as direct action lipoxygenase inhibitors (LOI) or of leukotriene synthesis inhibitors (LSI) with glucocorticosteroids (GCS). This combination is suitable for treating and preventing various acute and chronic inflammatory processes, in particular of the respiratory tract, and may therefore be used as a medicament, in particular for treating asthma.